(19)
(11) EP 3 723 729 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.11.2023 Bulletin 2023/44

(45) Mention of the grant of the patent:
27.09.2023 Bulletin 2023/39

(21) Application number: 18887975.3

(22) Date of filing: 11.12.2018
(51) International Patent Classification (IPC): 
A61K 9/08(2006.01)
A61P 29/00(2006.01)
 A61K 31/192(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0017; A61K 47/10; A61K 47/14; A61K 9/08; A61K 47/44; A61K 31/192; A61P 29/00; A61K 31/196; A61K 31/421; A61K 31/38; A61K 31/381; A61K 31/436
(86) International application number:
PCT/AU2018/000255
(87) International publication number:
WO 2019/113625 (20.06.2019 Gazette 2019/25)

(54)

TRANSDERMAL ANALGESIC FORMULATION

TRANSDERMALE ANALGETISCHE FORMULIERUNG

FORMULATION ANALGÉSIQUE TRANSDERMIQUE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 11.12.2017 AU 2017904975

(43) Date of publication of application:
21.10.2020 Bulletin 2020/43

(73) Proprietor: Meat & Livestock Australia Limited
North Sydney, NSW 2060 (AU)

(72) Inventors:
  • MILLS, Paul
    North Sydney, NSW 2060 (AU)
  • SATAKE, Nana
    North Sydney, NSW 2060 (AU)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)


(56) References cited: : 
EP-A2- 1 201 230
WO-A1-2012/022837
WO-A2-2009/063378
CA-C- 2 728 727
 WO-A1-01/02015
WO-A2-00/53228
WO-A2-2010/087947
US-A1- 2016 303 065
   
  • MA, XU et al.: "Effect of Counter-Ions and Penetration Enhancers on the Skin Permeation of Flurbiprofen", Journal of Pharmaceutical Sciences, vol. 99, no. 4, April 2010 (2010-04), pages 1826-1839, XP055617733,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).